107 related articles for article (PubMed ID: 4804294)
1. Immunological studies in melanoma patients treated with BCG.
De Vries JE; Rümke P
Br J Cancer Suppl; 1973 Aug; 1():97-102. PubMed ID: 4804294
[TBL] [Abstract][Full Text] [Related]
2. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
Nathanson L; Clark DA
Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
[No Abstract] [Full Text] [Related]
3. Immunological studies with human neoplasms.
Morton DL
J Reticuloendothel Soc; 1971 Jul; 10(1):137-60. PubMed ID: 4941264
[No Abstract] [Full Text] [Related]
4. [Multidisciplinary treatment of malignant melanoma of the nose and paranasal sinuses--with special reference to oral administration of enterosoluble BCG capsules].
Saito H; Hozawa J; Takagi A; Fukuoka K; Nozawa I; Kamimura T
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1555-61. PubMed ID: 6191718
[TBL] [Abstract][Full Text] [Related]
5. Effect of BCG immunotherapy on alloantigen-induced blastogenesis and cytotoxicity of lymph node lymphocytes in patients with melanoma.
Callery CD; Morton DL; Golub SH
Surg Forum; 1979; 30():152-4. PubMed ID: 161421
[No Abstract] [Full Text] [Related]
6. In vitro demonstration of cell-mediated immunity to human brain tumors.
Levy NL; Mahaley MS; Day ED
Cancer Res; 1972 Mar; 32(3):477-82. PubMed ID: 4334410
[No Abstract] [Full Text] [Related]
7. Neuraminidase immunotherapy of tumors in man.
Rosato FE; Brown AS; Miller EE; Rosato EF; Mullis WF; Johnson J; Moskovitz A
Surg Gynecol Obstet; 1974 Nov; 139(5):675-82. PubMed ID: 4428323
[No Abstract] [Full Text] [Related]
8. In vivo effect and parallel in vitro lymphocyte-mediated tumor cytolysis after Phase I xenogeneic immune RNA treatment of patients with widespread melanoma or metastatic renal cell carcinoma.
Steele G; Wang BS; Richie J; Wilson RE; Ervin T; Yankee R; Fallon M; Mannick JA
Cancer Res; 1980 Jul; 40(7):2377-82. PubMed ID: 6155992
[No Abstract] [Full Text] [Related]
9. Clinical experiences in immunotherapy of cancer.
Krementz ET; Samuels MS; Wallace JH; Benes EN
Surg Gynecol Obstet; 1971 Aug; 133(2):209-17. PubMed ID: 5284416
[No Abstract] [Full Text] [Related]
10. Anti-tumor immunoreactivity in patients with malignant melanoma.
Nairn RC; Nind AP; Guli EP; Davies DJ; Little JH; Davis NC; Whitehead RH
Med J Aust; 1972 Feb; 1(9):397-403. PubMed ID: 4554232
[No Abstract] [Full Text] [Related]
11. Immunological aspects of gliomas.
Ridley A
Proc R Soc Med; 1977 Dec; 70(12):867-9. PubMed ID: 601065
[No Abstract] [Full Text] [Related]
12. Induction of melanoma specific monocyte cytotoxicity in patients receiving BCG immunotherapy.
Dufour FD; Morton DL
Surg Forum; 1977; 28():165-7. PubMed ID: 617405
[No Abstract] [Full Text] [Related]
13. [Unspecific immunological investigations in patients with malignant melanoma (author's transl)].
Knopf B; Wätzig V
Dermatol Monatsschr; 1982 Jan; 168(1):24-33. PubMed ID: 7044849
[No Abstract] [Full Text] [Related]
14. A multiphase immunotherapy regimen for human melanoma: clinical and laboratory results.
Levy NL; Seigler HF; Shingleton WW
Cancer; 1974 Oct; 34(4 Suppl):suppl:1548-57. PubMed ID: 4421918
[No Abstract] [Full Text] [Related]
15. Significance of tumour associated antigens on human colonic carcinomata.
Embleton MJ
Br J Cancer Suppl; 1973 Aug; 1():142-52. PubMed ID: 4804277
[TBL] [Abstract][Full Text] [Related]
16. [Combination of surgery and immunotherapy in the treatment of melanoma. Experience of the National Institute of Oncology].
Beltrán-Ortega A; Ramírez-Ugalde MT; Mora-Tiscareño A
Gac Med Mex; 1978 Jan; 114(1):29-36. PubMed ID: 669131
[No Abstract] [Full Text] [Related]
17. [Cytotoxic index in melanoma patients].
Sviatukhin MV; Razmakhnina NG; Lysenkova EM
Vopr Onkol; 1977; 23(11):14-8. PubMed ID: 595509
[TBL] [Abstract][Full Text] [Related]
18. Lymphoid cells infiltrating human pulmonary tumors: effect of intralesional BCG injection.
Niitsuma M; Golub SH; Edelstein R; Holmes EC
J Natl Cancer Inst; 1981 Nov; 67(5):997-1003. PubMed ID: 6457925
[TBL] [Abstract][Full Text] [Related]
19. Chemoimmunotherapy increases the lymphocyte reactivity of melanoma patients.
Berkelhammer J; Mastrangelo MJ; Bellet RE; Berd D; Prehn RT
Eur J Cancer (1965); 1979 Feb; 15(2):197-204. PubMed ID: 436896
[No Abstract] [Full Text] [Related]
20. Immune responses to tumour and embryo cells in patients with mammary carcinoma.
Della Porta G; Canevari S; Fossati G
Br J Cancer Suppl; 1973 Aug; 1():103-7. PubMed ID: 4804274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
